<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="87406">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01989351</url>
  </required_header>
  <id_info>
    <org_study_id>IOGPGC03-13</org_study_id>
    <nct_id>NCT01989351</nct_id>
  </id_info>
  <brief_title>Predisposition to Persistent Pain After Orthopaedic Surgery: Genetic Aspects</brief_title>
  <official_title>LA PREDISPOSIZIONE AL DOLORE PERSISTENTE POST OPERATORIO IN AMBITO ORTOPEDICO: ASPETTI GENETICI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Gaetano Pini</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Gaetano Pini</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study purpose is to examine polymorphism of genes associated to post-operative
      persistent pain and to verify the possible association between genotype phenotype and ADRB2
      polymorphism in orthopaedic surgery. The primary aim is to evaluate the expression of ADBR2
      in VAS&gt;4 patients and to compare it to those with VAS&lt;4.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Frequency of SNPs rs12654788 and rs1042713 of ADBR2 gene in patients who complain persistent pain 4 months postoperatively compared to chronic pain free patients.</measure>
    <time_frame>4 months after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Expression frequency of OPRM1, COMT, IL1Ra</measure>
    <time_frame>6, 12, 24, 48 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum concentration of TNFα, TGFβ, IFNγ, IL-6 and IL-10 obtained with ELISA system</measure>
    <time_frame>6, 12, 24 and 48 hours postoperatively</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>VAS&lt;4</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>VAS&gt;4</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing total knee arthoplasty.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18

          -  ASA I to III

        Exclusion Criteria:

          -  Contraindications to regional anesthesia procedures

          -  Not stabilized neurological diseases

          -  Diabetes
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gianluca Cappelleri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istituto Ortopedico Gaetano Pini</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manuela de Gregori, Biologist</last_name>
    <role>Study Chair</role>
    <affiliation>Fondazione IRCCS Policlinico San Matteo - Pavia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Massimo Allegri, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Fondazione IRCCS Policlinico San Matteo - Pavia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gianluca Cappelleri, MD</last_name>
    <phone>+390258296297</phone>
    <email>gianluca.cappelleri@gpini.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istituto Ortopedico G. Pini</name>
      <address>
        <city>Milan</city>
        <state>Milano</state>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>gianluca cappelleri, MD</last_name>
      <phone>+390258296297</phone>
      <email>gianluca.cappelleri@gpini.it</email>
    </contact>
    <investigator>
      <last_name>gianluca cappelleri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 4, 2014</lastchanged_date>
  <firstreceived_date>November 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istituto Ortopedico Gaetano Pini</investigator_affiliation>
    <investigator_full_name>Gianluca Cappelleri</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
